CAS 2488788-52-7

RMC-0331

CAS : 2488788-52-7

RMC-0331

Degré de pureté : ≥98%

Masse moléculaire : 499.91g/mol

Ref: 54-BUP07471

RMC-0331

CAS : 2488788-52-7

RMC-0331 is an anticancer protein that has been shown to inhibit the growth of cancer cells in vitro. It is a potent inhibitor of kinase activity and has been found to induce apoptosis in various types of cancer cells, including those from Chinese hamster ovary (CHO) and human tumor cell lines. RMC-0331 is an analog of linezolid, a drug used to treat bacterial infections, and has been shown to have potent anticancer activity in animal models. This drug may be useful for the treatment of various types of cancer and could potentially be used in combination with other kinase inhibitors or chemotherapy agents. RMC-0331 can be detected in urine samples and may serve as a biomarker for monitoring the efficacy of this drug in cancer patients.

Formule : C₂₂H₂₅ClF₃N₅O₃

Degré de pureté : Min. 95%

Masse moléculaire : 499.9 g/mol

Ref: 3D-NZD78852

RMC-0331

CAS : 2488788-52-7

RMC-0331 (RM-023) is an oral SOS1 inhibitor with potential to block RAS activation and anticancer properties.

Formule : C₂₂H₂₅ClF₃N₅O₃

Degré de pureté : 97.84%

Couleur et forme : Solid

Masse moléculaire : 499.91

Ref: TM-T38170